Vident Advisory’s Thermo Fisher Scientific TMO Stock Holding History

Vident Advisory’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.23M	Buy	8,613 +2,652	+44%	+$1.44M	0.04%	399
2025 Q4	$3.45M	Buy	5,961 +373	+7%	+$211K	0.03%	417
2025 Q3	$2.71M	Buy	5,588 +588	+12%	+$274K	0.03%	468
2025 Q2	$2.03M	Sell	5,000 -738	-13%	-$309K	0.02%	497
2025 Q1	$2.86M	Buy	5,738 +1,092	+24%	+$591K	0.04%	366
2024 Q4	$2.42M	Sell	4,646 -11	-0.2%	-$6.05K	0.04%	370
2024 Q3	$2.88M	Buy	4,657 +1,083	+30%	+$641K	0.07%	298
2024 Q2	$1.98M	Buy	3,574 +408	+13%	+$234K	0.05%	376
2024 Q1	$1.84M	Buy	3,166 +166	+6%	+$93.1K	0.04%	392
2023 Q4	$1.59M	Sell	3,000 -86	-3%	-$41.6K	0.04%	434
2023 Q3	$1.56M	Buy	+3,086	New	+$1.64M	0.05%	377

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vident Advisory's TMO Position: Q1 2026 in Review

Vident Advisory increased its Thermo Fisher Scientific (TMO) stake by 44% in Q1 2026, buying an estimated $1.44M and bringing the position to 8,613 shares worth $4.23M. The position accounts for 0.04% of the portfolio, ranked #399.

Vident Advisory first reported a position in TMO in Q3 2023 and has held it in 11 quarters since. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Vident Advisory held 8,613 shares of Thermo Fisher Scientific worth $4.23M as of Q1 2026.
Vident Advisory bought 2,652 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.44M.
Thermo Fisher Scientific made up 0.04% of Vident Advisory's portfolio in Q1 2026, its #399 holding.
Vident Advisory first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 11 quarters since.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.